Labcorp Clinical Trials is a business segment of Labcorp Inc., a leading global life sciences company, which provides contract research services to the drug, medical device and diagnostics, crop protection and chemical industries. Labcorp is a registered trademark and the marketing name for Labcorp Inc. and its subsidiaries around the world.
2 stays of 10 nights & 5 OPVs
8472-370 3d 3d
Back To Current Studies2 stays of 10 nights & 5 OPVs
Study Number
8472-370 3dGroup
3dGender
bothAge
40 - 65Location
Dallas, TexasCompensation
$11,744Study Dates
Feb. 12 - Mar. 27, 2023Additional Information
The investigational drug in this research study is being developed for the treatment of breast cancer.
Labcorp Dallas, TX is recruiting for:
- Healthy Non-Smoking Males and Females of Non-Childbearing Potential, age 40-65
- Body Mass Index between 18-32
- Study involves 2 stays of 10 nights and 5 follow-up visits
- Compensation up to $11,744 may be provided for time and participation
- Receive up to $350 per qualified participant
Details
The purpose of Cohort 3 of this study is to measure how much of the study drug gets into the bloodstream, and how long it takes the body to get rid of it.
Group 3d:
Check-In: Feb 12, Mar 5
Check-Out: Feb 22, Mar 15
Outpatient Visit : Feb 27, Mar, 3, 20, 24, 27
OR
Group 3g:
Check-In: Feb 23, Mar 16
Check-Out: Mar 5, Mar 26
Outpatient Visit : Mar, 10, 14, 31, Apr 4, 7